In This Article:
WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Thursday reported a loss of $73.2 million in its first quarter.
On a per-share basis, the West Conshohocken, Pennsylvania-based company said it had a loss of $3.32.
The results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $3.62 per share.
The biopharmaceutical company posted revenue of $137.3 million in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $114 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MDGL at https://www.zacks.com/ap/MDGL